RAJENDER APARASU to Longitudinal Studies
This is a "connection" page, showing publications RAJENDER APARASU has written about Longitudinal Studies.
Connection Strength
0.812
-
Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer's Disease Initiating Cholinesterase Inhibitors. Drugs Aging. 2024 Apr; 41(4):339-355.
Score: 0.158
-
Prescribing of disease modifying agents in older adults with multiple sclerosis. Mult Scler Relat Disord. 2022 Jan; 57:103308.
Score: 0.134
-
Comparative treatment effectiveness of oral fingolimod and conventional injectable disease-modifying agents in multiple sclerosis. Pharmacotherapy. 2021 05; 41(5):440-450.
Score: 0.129
-
Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records. Mult Scler Relat Disord. 2020 Oct; 45:102334.
Score: 0.122
-
Anticholinergic drugs and health-related quality of life in older adults with dementia. J Am Pharm Assoc (2003). 2015 May-Jun; 55(3):282-7.
Score: 0.086
-
Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2012 Apr; 22(2):139-48.
Score: 0.069
-
Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients. Am J Geriatr Pharmacother. 2008 Oct; 6(4):198-204.
Score: 0.054
-
Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure. Am J Alzheimers Dis Other Demen. 2016 08; 31(5):395-404.
Score: 0.022
-
Use of Statins and Risk of Dementia in Heart Failure: A Retrospective Cohort Study. Drugs Aging. 2015 Sep; 32(9):743-54.
Score: 0.022
-
Risk factors for dementia in patients over 65 with diabetes. Int J Geriatr Psychiatry. 2011 Jul; 26(7):749-57.
Score: 0.016